Remission of histiocytic ulcerative colitis in boxer dogs correlates with eradication of invasive intramucosal Escherichia coli

Journal of Veterinary Internal Medicine

Volumn 23, Issue 5, 2009, Pages 964-969

  Mansfield, C S ^a   James, F E ^a   Craven, M ^b   Davies, D R ^a   O'Hara, A J ^a   Nicholls, P K ^a   Dogan, B ^b   MacDonough, S P ^b   Simpson, K W ^b  

^a MURDOCH UNIVERSITY   (Australia)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

16S rDNA; Adherent and invasive Escherichia coli; Canine; Colitis; Crohn's disease; Enrofloxacin; Fluorescent in situ hybridization

Indexed keywords

ANTIINFECTIVE AGENT; ENROFLOXACIN; QUINOLONE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOPSY; CLINICAL TRIAL; COLON; CYTOCHEMISTRY; DOG; DOG DISEASE; DRUG EFFECT; ESCHERICHIA; ESCHERICHIA COLI INFECTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GROWTH, DEVELOPMENT AND AGING; INTESTINE MUCOSA; MALE; MICROBIOLOGY; PATHOLOGY; PROSPECTIVE STUDY; ULCERATIVE COLITIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOPSY; COLITIS, ULCERATIVE; COLON; DOG DISEASES; DOGS; ESCHERICHIA; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HISTOCYTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINAL MUCOSA; MALE; PROSPECTIVE STUDIES;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 70349653176     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0363.x     Document Type: Article

References (33)

1. Van Kruiningen HM, Montali RJ, Strandberg JD, et al. A granulomatous colitis of dogs with histologic resemblance to Whipple's disease. Path Vet 1965;2:521-544.
2. Hill FW, Sullivan ND. Histiocytic ulcerative colitis in a Boxer dog. Aust Vet J 1978;54:447-449.
3. Lindberg R, Segall T. Histiocytic ulcerative colitis in a Boxer. A case report. Nord Vet Med 1977;29:552-555.
4. Hall EJ, Rutgers HC, Scholes SFE, et al. Histiocytic ulcerative colitis in Boxer dogs in the UK. J Small Anim Pract 1994;35: 509-515.
5. Churcher RK, Watson ADJ. Canine histiocytic ulcerative colitis. Aust Vet J 1997;75:710-713.
6. Van Kruiningen HJ. The ultrastructure of macrophages in granulomatous colitis of Boxer dogs. Vet Pathol 1975;12: 446-459.
7. Russell SW, Gomez JA, Trowbridge JO. Canine histiocytic ulcerative colitis. The early lesion and its progression to ulceration. Lab Invest 1971;25:509-515.
8. Cockrell BY, Krehbiel JD. Ultrastructural changes in histiocytic ulcerative colitis in a Boxer. Am J Vet Res 1972;33:453-459.
9. Bowe PS, van Kruiningen HJ, Rosendal S. Attempts to produce granulomatous colitis in Boxer dogs with a mycoplasm. Can J Comp Med 1982;46:430-433.
10. Davies DR, O'Hara AJ, Irwin PJ, et al. Successful management of histiocytic ulcerative colitis with enrofloxacin in two Boxer dogs. Aust Vet J 2004;82:50-54.
11. Hostutler RA, Luria BJ, Johnson SE, et al. Antibiotic-responsive histiocytic ulcerative colitis in 9 dogs. J Vet Int Med 2004;18:499-504.
12. Simpson KW, Dogan B, Rishniw M, et al. Adherent and invasive Escherichia coli is associated with granulomatous colitis in Boxer dogs. Infect Immunity 2006;74:4778-4792.
13. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;30:293-301.
14. Van Kruiningen HJ, Civco IC, Cartun RW. The comparative importance of E. coli antigen in granulomatous colitis of Boxer dogs. Acta Pathol Microbiol Immunol 2005;113:420-425.
15. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405-1413.
16. Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of clostridiales in Crohn's disease involving the ileum. Int Soc Microb Ecol J 2007;1:403-418.
17. Shryock T, Apley M, Jones R, et al. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Nat Com Clin Lab Stand 2002;22:M31-A2.
18. Ryan P, Kelly RG, Lee G, et al. Bacterial DNA within granulomas of patients with Crohn's disease-detection by laser capture microdissection and PCR. Am J Gastroenterol 2004;99:1539-1543.
19. Rhodes JM. The role of Escherichia coli in inflammatory bowel disease. Gut 2007;56:610-612.
20. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127: 412-421.
21. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest 2007;87: 1042-1054.
22. Arnott ID, Landers CJ, Nimmo EJ, et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004;99:2376-2384.
23. Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1277-1283.
24. Hanauer SB. Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 2006;12(Suppl 1):S3-S9.
25. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-1633.
26. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008;8:458-466.
27. Stenner VJ, MacKay B, King T, et al. Protothecosis in 17 Australian dogs and a review of the canine literature. Med Mycol 2007;45:249-266.
28. Malik R, Love DN, Wigney DI, et al. Mycobacterial nodular granulomas affecting the subcutis and skin of dogs (canine leproid granuloma syndrome). Aust Vet J 1998;76:403-407.
29. Schneider T, Moos V, Loddenkemper C, et al. Whipple's disease: New aspects of pathogenesis and treatment. Lancet Infect Dis 2008;8:179-190.
30. Cooke CL, Singer RS, Jang SS, et al. Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections. J Am Vet Med Assoc 2002;220:190-192.
31. Warren AL, Townsend KM, King T, et al. Multi-drug resistant Escherichia coli with extended-spectrum b-lactamase activity and fluoroquinolone resistance isolated from clinical infections in dogs. Aust Vet J 2001;79:621-623.
32. Subramanian S, Roberts CL, Hart CA, et al. Replication of colonic Crohn's disease mucosal Escherichia coli isolates within macrophages and their susceptibility to antibiotics. Antimicrob Agents Chemother 2008;52:427-434.
33. Subramanian S, Rhodes JM, Hart CA, et al. Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. Inflamm Bowel Dis 2008;14:162-175.